Recs

0

Toyota Running Hot

It's been a heckuva ride for Japan's largest car company, Toyota (NYSE: TM  ) . While American makers like Ford (NYSE: F  ) and General Motors (NYSE: GM  ) implode, Toyota goes merrily on its way to building arguably the best global auto and light-truck franchise.

Fourth-quarter results certainly didn't slide off the road. Sales were up about 18%, while reported operating income rose 53%, and net income climbed 39%. Free cash flow growth was also quite strong on a year-over-year basis, though a bit more restrained when it came to structural free cash flow (a.k.a. owner earnings).

Production rose 7% in the fourth quarter, and vehicle sales (measured in units) were up 8% -- matching the full-year result. The company specifically stated that it added share in Japan (approaching 46%), and though it didn't provide statistics on the North American markets, I'll bet it continues to gain share over here as well.

While investors often focus on Toyota's U.S. performance and talk about its lead in new technologies like hybrids, I wouldn't ignore its performance in Japan, either. Based on my reading of the numbers, Japanese sales are more than twice as profitable as U.S. sales on an operating-margin basis. Japan is an invaluable cash-generating segment for Toyota, with sales nearly twice those in North America.

Toyota is in a great position. It has well-liked brands and free cash to invest in new (and state-of-the-art) plants and plentiful R&D. What's more, Toyota can manage earnings to some extent; profits above its long-term targets can be reinvested in R&D during fat years or trimmed back as needed in lean ones.

I'd like to hear a bit more from Toyota about ethanol-powered automobiles, since that segment might be General Motors' and Ford's best chance to regain some strength. Unlike hydrogen, ethanol is easy to dispense via current technologies, and countries like Brazil have successfully used it as all but a replacement for gasoline.

Having climbed more than 50% over the past year, it's hard to call this stock a bargain, and currency moves could make business a bit more challenging. Still, my cash flow model doesn't suggest that it's too overvalued, and it's not always wise to part with best-of-breed stocks just because of a few percentage points' deviation from fair value.

Drive on for further Foolishness:

Want to pack your portfolio with more global powerhouses? Learn the Fool's picks for the best stocks worldwide in the pages of our International Report.

Fool contributor Stephen Simpson has no financial interest in any stocks mentioned (that means he's neither long nor short the shares).


Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

DocumentId: 513761, ~/Articles/ArticleHandler.aspx, 2/13/2012 11:51:28 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 12,859.13 57.90 0.45%
S&P 500 1,349.21 6.57 0.49%
NASD 2,922.75 18.87 0.65%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

2/13/2012 11:26 AM
TM $78.79 Up +0.40 +0.51%
Toyota Motor Corp… CAPS Rating: ***
GM $25.55 Up +0.05 +0.20%
General Motors Com… CAPS Rating: **
F $12.53 Up +0.09 +0.72%
Ford CAPS Rating: ****

Advertisement